Optimizing Therapeutic Combinations of a Selective MEK 1/2 Inhibitor (Pimasertib) With PI3K/MTOR Inhibitors or With Multi-Targeted Kinase Inhibitors in Pimasertib-Resistant Human Lung and Colorectal Cancer Cells
Keyword(s):
2013 ◽
Vol 133
(9)
◽
pp. 2089-2101
◽
Keyword(s):
Keyword(s):
1997 ◽
Vol 240
(3)
◽
pp. 606-611
◽
Keyword(s):
2010 ◽
Vol 159
(6)
◽
pp. 1326-1338
◽
Keyword(s):